Snowball logo
logo
GXGX

GX Acquisition Corp

GXGX NASDAQ Не торгуется
-- $0,00 $  (0%)
Оценка
EPS
-0,49
Рост
Чистый доход, YoY
3 611,28%
FCF, YoY
18,83%
Прогноз
EPS (FWD)
-0,68
Другое
Размер лота
1 шт.
О компании
Тикер
GXGX
ISIN
US36251A1079
Страна
США
Сектор (GICS)
Финансы
Celularity Inc., a biopharmaceutical company, develops placental-derived off-the-shelf therapeutic and cellular medicines for cancer, infectious diseases, and degenerative diseases. The company offers Biovance, a human amniotic membrane allograft that provides a protective cover and supports the body's wound healing processes; and Interfyl, a connective tissue matrix for various surgical applications when there is a need to replace and supplement damaged or inadequate integumental tissue. It also offers allogeneic placenta-derived cell therapy product candidates. The company was incorporated in 2016 and is based in Florham Park, New Jersey.

Часто задаваемые вопросы

В каком секторе работает GX Acquisition Corp (GXGX)?

GX Acquisition Corp относится к сектору Финансы.

Выплачивает ли GX Acquisition Corp (GXGX) дивиденды?

Нет, GX Acquisition Corp не выплачивает дивиденды.